## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1860.79)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Moody’s Rating Upgrades MercadoLibre, Inc. (MELI), Here’s Why**
- Source: Insider Monkey | 20251221T094500 | Bullish | Relevance: 100%
- Moody's Ratings has upgraded MercadoLibre, Inc. (MELI) to investment grade with a Baa3 issuer rating and a stable outlook, citing improved debt levels, cash flow, profitability, and fintech transparency. This upgrade signifies a lower-risk investment. Additionally, MercadoLibre announced a strategic agreement with Agility Robotics to integrate Digit humanoid robots into its fulfillment facilities to enhance productivity and worker safety.

**2. CCLA Investment Management Acquires Shares of 38,946 MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251222T100836 | Somewhat-Bullish | Relevance: 100%
- CCLA Investment Management has acquired a new stake of 38,946 shares in MercadoLibre, Inc. ($MELI) during the third quarter, valued at approximately $91.01 million. Despite insider selling totaling 1,136 shares worth about $2.31 million in the last three months, MercadoLibre maintains a consensus "Moderate Buy" rating from sell-side analysts with a target price of $2,842.94. The company's stock performance and financial metrics are detailed, with institutional investors and hedge funds owning 87.62% of the stock.

**3. Exchange Traded Concepts LLC Acquires 1,755 Shares of MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251222T100836 | Neutral | Relevance: 100%
- Exchange Traded Concepts LLC has increased its stake in MercadoLibre (NASDAQ:MELI) by 14.3%, acquiring an additional 1,755 shares, bringing their total holdings to 13,987 shares valued at $32.69 million. This comes amidst recent insider selling, with directors and insiders offloading a total of 1,136 shares. Despite missing Q3 EPS estimates, MercadoLibre saw a 39.5% revenue increase and holds a "Moderate Buy" consensus rating from analysts.

**4. Flputnam Investment Management Co. Grows Stock Position in MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251221T120928 | Neutral | Relevance: 100%
- Flputnam Investment Management Co. significantly increased its stake in MercadoLibre, Inc. (NASDAQ:MELI) by 1,395.1% in the third quarter, now holding 7,012 shares valued at $16.39 million. This move is part of a broader trend of institutional investors growing their positions, while company insiders have recently sold shares. MercadoLibre reported mixed Q3 results with revenue beating estimates but EPS missing, and the stock currently holds a "Moderate Buy" rating from analysts.

**5. MercadoLibre, Inc. $MELI Shares Sold by Sarasin & Partners LLP**
- Source: MarketBeat | 20251221T130928 | Neutral | Relevance: 100%
- Sarasin & Partners LLP reduced its holding in MercadoLibre, Inc. (NASDAQ:MELI) by 4.3% in the third quarter, while other institutions like Lavaca Capital LLC and Norges Bank significantly increased their stakes. Insider selling totaled $2.31 million over the last three months, though institutional ownership remains high at 87.62%. MercadoLibre recently missed EPS estimates but exceeded revenue expectations, with analysts maintaining a "Moderate Buy" consensus target.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wedbush | $2700 | $2800 | -4% |
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wedbush | main | Outperform |
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 12.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.97 indicates undervaluation relative to growth. Forward P/E 33.4x attractive for 49% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $101.1B |
| Beta | 1.43 |
| 52W Range | $1693.01 - $2645.22 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.97 |
| Forward P/E | 33.4 |
| Current P/E | 49.8 |
| YoY Growth | 49.2% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -2.3% to -0.4% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). Below SMA200 (0.88x), long-term trend not supportive. MACD histogram positive (1.46), confirming momentum. RSI neutral at 45. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.40% (CS: 62) | Neutral |
| RSI_14 | 45.2 | Neutral |
| MACD Histogram | 1.46 | Bullish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 0.953x | Below |
| vs SMA200 | 0.880x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1995.07
- **Stop Loss:** $1860.79 (6.7% risk)
- **Target:** $2129.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 6
- **Position Value:** $11,970.42
- **Portfolio %:** 11.97%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*